Vilya-2 predicts bound structures of chemically diverse peptides and small molecules at state-of-the-art accuracy using an all-atom diffusion transformer, recovering 59.1% of peptide interfaces to sub-2 Å backbone RMSD.
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.LG 1years
2026 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Accurate structural modeling of chemically diverse molecular interfaces with Vilya-2
Vilya-2 predicts bound structures of chemically diverse peptides and small molecules at state-of-the-art accuracy using an all-atom diffusion transformer, recovering 59.1% of peptide interfaces to sub-2 Å backbone RMSD.